Company Directory > Digital Health > BlueBridge Technologies
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of BlueBridge Technologies and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
BlueBridge Technologies is a Dublin-based digital health and medtech engineering partner specializing in the development of Software as a Medical Device (SaMD). The company bridges the gap between science and technology by providing end-to-end solutions, including regulatory strategy, clinical research support, and the development of intelligent software for connected medical devices. Their expertise spans cloud, mobile, and wearable technology, with a strong focus on compliance with international standards such as ISO 13485, ISO 14971, and IEC 62304. They serve a global portfolio of blue-chip biopharma and medical device companies, helping them accelerate time-to-market for digital therapeutics, diagnostics, and monitoring solutions.
CLASSIFICATION
Company Type:Digital Health
Industry:Digital Health
Sub-Industry:Medtech Regulatory & Engineering Services
SIZE & FINANCIALS
Employees:1-50
Founded:2006
Ownership:private
Status:operating
FUNDING
Stage:Grant-funded
Investors:EIC Fund, Horizon 2020, DIT Hothouse
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Service provider)
Modalities:Digital Therapeutics, Software as a Medical Device (SaMD), Wearables, Cloud-based diagnostics
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Medical Device Innovation Consortium (MDIC), Various global biopharma and medical device companies (client portfolio)
COMPETITION
Position:Niche Player
Competitors:Innovaccer, Veeva Systems, NextGen Healthcare
LEADERSHIP
Key Executives:
Garret Coady - CEO
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with BlueBridge Technologies. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.